• RenovoRx

  Participated · Series B · Jan 2014

  RenovoRx is a clinical‑stage biopharmaceutical company developing RenovoGem, an oncology drug‑device combination delivered via its proprietary TAMP platform. Its lead program is the pivotal TIGeR‑PaC Phase III study in locally advanced pancreatic cancer, with a primary endpoint of a 6‑month overall survival benefit and secondary endpoints assessing reduced side effects versus standard intravenous chemotherapy. The first interim analysis (26th event) was completed in March 2023 with the Data Monitoring Committee recommending continuation; a second interim analysis is expected at the 52nd event in late 2024. Data from the program have been presented at major oncology meetings, and the company plans a second late‑stage CouGar Phase III study in bile duct cancer. RenovoRx has identified additional potential indications (NSCLC, uterine tumors, glioblastoma, sarcoma) but will require more funding to pursue them. The company says the recent financing bolsters its balance sheet to advance late‑stage programs and reach near‑term clinical milestones. RenovoRx develops the RenovoCath, a dual-balloon infusion catheter designed to isolate blood flow and deliver chemotherapy directly to pancreatic tumors without identifying local blood vessels. The company received FDA clearance for RenovoCath in 2014, a CE Mark in 2015, and expanded FDA labeling in 2017. Based on early feasibility data, the targeted intra-arterial approach suggested an improved survival benefit versus historical controls for locally advanced pancreatic cancer. The FDA granted RenovoCath an Orphan Drug Designation and approved an Investigational New Drug (IND) application enabling the company to proceed directly to a pivotal Phase III study. Enrollment has begun in a randomized Phase III trial comparing intra-arterial chemotherapy via RenovoCath to systemic chemotherapy in ~300 patients at up to 20 U.S. sites, with overall survival as the primary endpoint and safety and quality of life as secondary endpoints. The announced financing will be used to support ongoing product development and these clinical trials. RenovoRx, founded in 2009 and based in San Jose, California, develops novel catheter technologies to deliver fluids to the peripheral vascular system. Its system enables direct, localized delivery of fluids, including radiopaque material and therapeutic agents, to selected sites. The company is led by CEO Marta Gaia Zanchi, COO/CTO Kamran Najmabadi, and CMO Ramtin Agah. In January 2014 RenovoRx closed a $1.15M Series B financing to advance its program. Management says the proceeds will be used to support important milestones and to meet clinical need for its system in 2014. The financing reflects continued investor interest as the company progresses toward clinical objectives.

• Mozio

  Participated · Seed · Oct 2012

  Mozio builds an urban mobility app that aggregates shuttles, taxis, limos, trains, buses, public transit and other ground-transportation options into a single booking interface. The company’s platform enables travelers to search for and book the right last-mile option when traveling to and from airports. Mozio partners with consumer travel brands such as Booking.com, Hotels.com and Skyscanner and with corporate travel firms including Carlson Wagonlit Travel, American Express Business Travel and BCD Travel. The firm has 65 employees across offices in San Francisco, London, Argentina and Portugal. Founded in 2012, Mozio has previously raised $3.3M in venture capital from Silicon Valley VCs and strategic investors such as Veolia Transdev North America and JetBlue Technology Ventures. Management has said it plans to develop more distribution partners and further extend its platform, and views strategic investors like JetBlue Technology Ventures as key partners in that effort. Mozio operates an airport ground transportation search engine and a B2B white-label solution that aggregates fares for taxis, trains, buses, ferries, shuttles, limos and other local transport options. Its airport transfer search covers over 1,000 airports and 800 transportation providers, with the strongest coverage in the U.S. and additional presence in Europe, Latin America, Canada, Australia and Asia. While Mozio offers a public-facing search engine, its primary business is white-label B2B integrations with larger travel sites. The company was co-founded by UC Berkeley graduates David Litwak and Joseph Metzinger based on Litwak’s travel experiences. Operationally, Mozio reported doing over 100,000 bookings in one month and growing at roughly 20% month-over-month. It has begun strategic partnerships (including a deal with ride-share platform Wingz) and is working on a deal with Amtrak. Mozio plans to expand into more geographies, add additional transportation types such as ride-share and water taxis, and is hiring to grow its team. Mozio aggregates limos, taxis, ride shares, shuttles, shared vans, and public transit to help travelers navigate the "final mile" between airports and their destinations. The platform integrates through the APIs of participating ground-transportation providers and partners with both national and local operators to present a comprehensive picture of options. The company emphasizes that cost, timing, convenience, and comfort vary by city and aims to surface the best choice for each trip. Mozio is still early-stage and is building out its partnership network while developing its own API. It has generated interest from companies including TripAdvisor and Orbitz. The company has raised $185,000 in startup capital and operates with a three-person team based in San Francisco.

• Rover

  Participated · Seed · Nov 2008

  Flipora is a Sunnyvale, CA-based content discovery application founded by Jonathan Siddharth and Vijay Krishnan. It uses artificial intelligence to let users follow interests and publications, connect with other users around shared interests, and receive a personalized feed of content recommendations. The company offers a free service with apps for iPhone, Android and a web offering. With this seed round, Flipora is launching updated mobile apps for iPhone and Android to complement its existing web product. The company raised $1.5M in seed funding from a group of individual backers. Backers named in the article include Gokul Rajaram, Barney Pell, Munjal Shah, Anil Dharni and Mayank Bawa. Founded in 2008, InfoAxe offers an alternative search engine that focuses on indexing individual users' browsing history to surface more contextual and personalized results. The product includes a toolbar that records public web browsing sessions so users can search their personal history from the toolbar or the InfoAxe website. Last fall the company launched a real-time search engine that leverages attention data generated by its web-history search. InfoAxe reports 4 million users and says it is bookmarking 20 million webpages per day based on user activity on the platform. Co-founder Jonathan Siddharth says the company is approaching profitability and is currently looking to hire more engineers. Infoaxe offers a toolbar (IE and Firefox) that records public web browsing sessions and makes personal web history searchable from the toolbar or the Infoaxe website. The product augments traditional search results with additional results drawn from a user’s recorded “web memory” and imports Delicious bookmarks into its indexed data. It also supports tagging and sharing of pages and includes a “Pivot” feature to search history by timeframe. The company positions itself against social-bookmarking services like Delicious and ma.gnolia and similar-history tools such as WebMynd. In the future Infoaxe aims to act as a discovery engine by offering personalized recommendations based on web history. Infoaxe is currently in alpha and was developed by Jonathan Siddharth and Vijay Krishnan while they were grad students at Stanford; the company raised seed funding in March 2008.

• VentureBeat

  Participated · Seed · Feb 2008

  VentureBeat is a San Francisco-based tech news website founded in 2006 and led by CEO Matt Marshall. It provides breaking news and reporting on technology trends such as social, mobile, small business, enterprise, big data, cloud services, and games. The company also operates executive-level conferences including MobileBeat, GamesBeat, VentureBeat Mobile Summit, DataBeat, HealthBeat, and GrowthBeat. VentureBeat reaches 7.5 million readers per month (Google Analytics & internal metrics). It raised $2.6M in funding to finance a new research division, VB Insight. VB Insight will provide independent, analyst-driven research to help marketing and IT leaders make informed decisions, initially focusing on SaaS segments such as Marketing Automation, Mobile Developers, and Digital Advertising. VentureBeat is a venture-focused blog founded in 2006 by former San Jose Mercury News writer Matt Marshall that aims to provide insider news and data about the entrepreneurial and venture community for decision makers. The site publishes industry reporting and has recently signed high-profile journalist Dean Takahashi. VentureBeat positions itself in a "funded blog network" alongside outlets like GigaOm. The company completed a seed financing to support growth and site development. Management says the funds will be used to take the site to the next stage and will presumably cover staffing costs such as Takahashi’s salary. No operating metrics or revenues are disclosed in the article.

No current team members are available.